BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Augustin E, Niemira M, Hołownia A, Mazerska Z. CYP3A4-dependent cellular response does not relate to CYP3A4-catalysed metabolites of C-1748 and C-1305 acridine antitumor agents in HepG2 cells. Cell Biol Int 2014;38:1291-303. [PMID: 24890801 DOI: 10.1002/cbin.10322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Q, Wu H, You C, Gao Z, Sun K, Wang M, Chen F, Sun B. 1,3-dimethyl-6-nitroacridine derivatives induce apoptosis in human breast cancer cells by targeting DNA. Drug Dev Ind Pharm 2019;45:212-21. [PMID: 30256663 DOI: 10.1080/03639045.2018.1529185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Zhou Q, You C, Zheng C, Gu Y, Gu H, Zhang R, Wu H, Sun B. 3-Nitroacridine derivatives arrest cell cycle at G0/G1 phase and induce apoptosis in human breast cancer cells may act as DNA-target anticancer agents. Life Sci 2018;206:1-9. [PMID: 29738780 DOI: 10.1016/j.lfs.2018.05.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
3 Gabriel I, Rząd K, Paluszkiewicz E, Kozłowska-Tylingo K. Antifungal Activity of Capridine β as a Consequence of Its Biotransformation into Metabolite Affecting Yeast Topoisomerase II Activity. Pathogens 2021;10:189. [PMID: 33572407 DOI: 10.3390/pathogens10020189] [Reference Citation Analysis]
4 Weyers C, Dingle LMK, Wilhelmi BS, Edkins AL, Veale CGL. Use of a non-hepatic cell line highlights limitations associated with cell-based assessment of metabolically induced toxicity. Drug Chem Toxicol 2020;43:656-62. [PMID: 30880486 DOI: 10.1080/01480545.2019.1585869] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Ježek J, Hlaváček J, Šebestík J. Interactions with Proteins. Biomedical Applications of Acridines. Cham: Springer International Publishing; 2017. pp. 73-97. [DOI: 10.1007/978-3-319-63953-6_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Mangueira VM, Batista TM, Brito MT, Sousa TKG, Cruz RMDD, Abrantes RA, Veras RC, Medeiros IA, Medeiros KKP, Pereira ALDC, Serafim VL, Moura RO, Sobral MV. A new acridine derivative induces cell cycle arrest and antiangiogenic effect on Ehrlich ascites carcinoma model. Biomed Pharmacother 2017;90:253-61. [PMID: 28364597 DOI: 10.1016/j.biopha.2017.03.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
7 Pawłowska M, Kwaśniewska A, Mazerska Z, Augustin E. Enhanced Activity of P4503A4 and UGT1A10 Induced by Acridinone Derivatives C-1305 and C-1311 in MCF-7 and HCT116 Cancer Cells: Consequences for the Drugs' Cytotoxicity, Metabolism and Cellular Response. Int J Mol Sci 2020;21:E3954. [PMID: 32486425 DOI: 10.3390/ijms21113954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]